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Abstract 
Objectives: Histatin, with its anti bacterial, anti protease, and wound closure stimulating property might influence 
the pathogenesis of periodontal disease. This study assessed the presence of histatin in gingival crevicular fluid 
(GCF); the levels of salivary and GCF histatin in periodontal disease.
Material and methods: It was a cross sectional study that included systemically healthy forty five subjects (22 males 
and 23 females) between the age group of 20 to 45 years. Based on Gingival Index (Loe and Silness ,1963) and 
Russell’s Periodontal Index they were grouped as 15 healthy (Group 1), 15 gingivitis (Group 2), and 15 periodon-
titis (Group 3) subjects. Whole pooled unstimulated saliva was collected by asking the patient to spit in a sterile 
container and GCF samples were collected using a micropipette from all the subjects. Histatin levels were assessed 
using Enzyme Linked Immunosorbent Assay (ELISA). The intergroup comparison was done by ANOVA and Mann 
Whitney U Test was done for pair wise comparison.
Results: The results of this study show that histatin is present in saliva and gingival crevicular fluid. When the 
salivary histatin levels were compared it was found that the levels of histatin increase from health to periodontitis 
but the levels of histatin in the gingival crevicular fluid and saliva had no correlation with severity of periodontal 
disease as there was no statistically significant difference between the three groups. 
Conclusions: It can be concluded that histatin cannot be used as a potential marker of periodontal disease.
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Introduction
Histatins are a group of small, cationic histidine-rich 
peptides secreted by human salivary glands. A number 
of different biological functions have been ascribed to 
the histatins: It is involved in the formation of acquired 
enamel pellicle (1), binds to the Porphyromonas gingi-
valis and inhibits its trypsin like activity (2). It has anti 
fungal and bactericidal activity (3,4). It prevents coag-
gregation, inhibits bacterial proteases at physiological 
concentration and has wound closure stimulating pro-
perty (5-7). It has shown to reduce the clinical signs of 
gingival inflammation and plaque formation (8). These 
characteristics of histatins are a good reason to investi-
gate any possible role played by them in the periodontal 
disease (P.D.).
In order to find the role played by histatins in the patho-
genesis of periodontol disease their presence in the gin-
gival crevicular fluid (GCF) needs to be investigated and 
its relation to periodontal health and disease evaluated.
Considering the strong analogy that exists between sali-
va and gingival crevicular fluid (GCF) as potential sour-
ces of PD markers and the already known presence of 
histatin in saliva (9), the possible presence of histatin in 
GCF and its role in PD was considered. Hence this study 
aimed to evaluate the presence of histatin in GCF, assess 
the levels of salivary and GCF histatin in periodontal 
health and disease.
Material and Methods
Forty five subjects (23 females and 22 males), in the age 
range 20 to 45 years, were recruited for the study that 
was conducted in June and July of 2010, at the Sri Dhar-
masthala Manjunatheshwara College of Dental Sciences 
and Hospital, Dharwad, India. Informed written consent 
was obtained from all subjects before starting the study. 
The ethical clearance was obtained from this institution. 
Three groups with 15 subjects each were designated as 
Group 1 (clinically healthy), based on Gingival Index 
(10) score of 2 and 3, Group 2 (gingivitis), based on 
Russell’s Periodontal Index (1967) (11) score of 6 and 
8 as Group 3 (chronic generalized periodontitis) respec-
tively. Group 3 included the chronic generalized perio-
dontitis group with moderate to severe type.
Subject inclusion criteria:
1. Healthy subjects and patients with varying degree 
of periodontal disease.(Gingivitis and chronic gene-
ralized periodontitis).
2. Good general health.
3. No periodontal therapy in the past 6 months.
Subject exclusion criteria:
1. Patients with any systemic disorder like diabetes 
mellitus, hypertension etc.
2. Patients with a known disorder of the salivary 
gland.
3. Presence of any disorder that might alter the im-
mune system.
4. Patients on any medication that might alter the sali-
vary flow rate or composition. E.g. Beta blockers.
5. Patients who had been administered antibiotics in 
the past 6 months.
6. Patients consuming tobacco in any form were ex-
cluded from the study as the relation of tobacco and 
histatin levels is not ascertained till date.
A dental and medical history was compiled for all subjects 
with an oral examination, including caries assessments. 
Gingival Index and Russell’s Periodontal Index scores 
were collected for each subject. The same investigator 
performed all data collection and examinations.
- Determination of Salivary and GCF Histatin:
Collection of saliva• 
Participants were asked to refrain from drinking or ea-
ting half an hour before collection of saliva sample.
Both test and control subjects reported to the hospital 
between 10.00 am and 2.00 pm. One millilitre (ml) of 
unstimulated pooled whole saliva was collected by as-
king the patient to spit in a sterile container. The patients 
were told to avoid spitting forcefully in order to avoi-
ding any possible contamination. The saliva samples 
were centrifuged at 3000 × g for 20 minutes, and the 
clear supernatant was stored at – 70°C until assay was 
performed.
Collection of GCF• 
Multiple test sites were dried and isolated with cotton 
rolls to prevent any contamination from saliva and 
blood. Prior to GCF sampling, supragingival calculus 
was removed using sterile curette. A standard volume 
of 2 μl was collected extracrevicularly using a calibra-
ted, volumetric, microcapillary pipette measuring 1 to5 
μl with a plunger for 5 to 30 minutes. Pooled volume 
of GCF was collected for healthy subjects where as for 
gingivitis and periodontitis site specific sampling was 
followed. Samples were collected from sites exhibiting 
severe inflammation with Gingival Index score of 2 and 
3 for gingivitis group (Group 2) and sites exhibiting a 
probing depth of >5 mm for periodontitis group (Group 
3). On visual examination, test sites which did not ex-
press any volume of GCF and micropipettes contamina-
ted with blood and saliva were not included in the study. 
The GCF obtained was stored at – 80°C until the assay 
was performed.
- Histatin determination:
It was determined by using a sandwich ELISA technique 
as described by Jensen et al (12). Saliva was diluted to 
1:100 dilution by addition of 4 µl of saliva to 400 µl 
of phosphate buffered saline. 50 µl of this sample was 
added to each well.
Gingival crevicular fluid was also diluted to 1: 100 whe-
re 2 µl of GCF was added to 200 µl of phosphate buffe-
red saline and 50 µl of this sample was added to each 
well. PBS was used as blanks. Histatin 5 $ (range, from 
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31.2 ng/mL to 2 µg/mL) were used as standards. The ab-
sorbance was read at 450nm in a microtitre plate reader.
$sc-28111 Santa Cruz®, USA
- Statistical evaluation:
The data collected was entered in Microsoft Office Ex-
cel Format and statistical analysis was done using SPSS 
software.§ One-way ANOVA was done to test the signi-
ficant difference between the groups. Statistical signifi-
cance was established at P <0.05. 
Results
All the values are expressed as optical density and the p 
value <0.05 is considered to be statistically significant.
All the samples in each group showed the presence of 
histatin. (Table 1) The highest concentration being in 
group 3 for salivary histatin. The histatin readings range 
from 0.510 in healthy subjects to 0.865 in subjects with 
periodontitis. The mean for healthy subjects was 0.667, 
for gingivitis was 0.7093 and for periodontitis was 
0.7253. All the gingival crevicular fluid samples showed 
the presence of histatin. (Table 2) The histatin readings 
for gingival crevicular fluid did not show any ordered 
rise or fall with level of periodontal disease. These va-
lues show that there is a negligible difference in hista-
tin levels in the gingival crevicular fluid with increase 
in severity of disease, i.e., from health to gingivitis and 
to periodontitis. With mean values for health, gingivitis 
Histatin concentration in saliva
Subject Clinically healthy
(Group I)
Gingivitis
(Group II)
Periodontitis
(Group III)
1 0.575 0.795 0.809
2 0.650 0.714 0.636
3 0.566 0.763 0.641
4 0.704 0.510 0.697
5 0.510 0.760 0.651
6 0.650 0.694 0.663
7 0.634 0.650 0.759
8 0.747 0.770 0.865
9 0.653 0.541 0.777
10 0.762 0.558 0.672
11 0.651 0.810 0.779
12 0.705 0.734 0.788
13 0.704 0.750 0.650
14 0.700 0.783 0.724
15 0.789 0.808 0.769
Mean 0.6667 0.7093 0.7253
Histatin concentration in gingival crevicular fluid 
Subject Clinically healthy
(Group I)
Gingivitis
(Group II)
Periodontitis
(Group III)
1 0.817 0.561 0.656
2 0.522 0.684 0.546
3 0.651 0.571 0.507
4 0.562 0.434 0.182
5 0.684 0.580 0.601
6 0.470 0.598 0.700
7 0.613 0.714 0.734
8 0.563 0.865 0.679
9 0.743 0.472 0.852
10 0.566 0.742 0.518
11 0.807 0.710 0.759
12 0.654 0.744 0.705
13 0.594 0.607 0.637
14 0.125 0.626 0.756
15 0.687 0.593 0.665
Mean 0.6381 0.6334 0.6654
Table 1. Concentrations of histatin in saliva of Group I, Group II and 
Group III.
Table 2. Concentration of histatin in gingival crevicular fluid of Group 
I, Group II and Group III.
Group Means Std.Dev. Sum of ranks
Group I 0.6667 0.0761 263.0000
Group II 0.7093 0.0996 384.0000
Group III 0.7253 0.0721 388.0000
H-value  3.9044  
P-value  0.1420  
 Pair wise comparison by Mann-Whitney U test
Grp I vs Grp II  0.0971  
Grp I vs Grp III  0.0815  
Grp II vs Grp III  0.9669  
Grp: Group.
Std Dev: Standard deviation.
GCF: gingival crevicular fluid.
Table 3. Comparison of the GCF histatin levels in the three groups by 
Kruskal Walllis ANOVA.
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and periodontitis being 0.6381,0.6334 and 0.6654 res-
pectively.
One-way ANOVA was used to test the significant diffe-
rence between the groups and a no significance differen-
ce in the mean concentration of histatin was observed in 
both saliva and GCF (Table 3, Table 4). Mann Whitney 
U test was done for the inter group comparison. (Table 3, 
Table 4). The p values for Salivary histatin in intergroup 
comparison were 0.0971, 0.0815, 0.9669 and none were 
statistically significant. The p values with GCF hista-
tin were 0.8035,0.3095 and 0.4186 which also failed to 
show statistical significance.
The results suggest that the levels of salivary and GCF 
histatin did increase slightly from health to disease but it 
was not statistically significant.
§ SPSS statistical package (PC version 7.0), SPSS, 
Chicago,IL.
Discussion
With respect to the subject selection, systemically healthy 
subjects were chosen as not much literature was availa-
ble as to which systemic conditions can influence hista-
tin secretion. Moreover, any disorder of salivary glands 
or the immune system is bound to alter histatin secretion 
and therefore, the subjects with either of the above were 
excluded. As β blockers tend to cause decreased histatin 
secretion, subjects on these medications in particular and 
any other medication in general were not recruited (12). 
Equal number of males and females were recruited to 
prevent bias due to gender but it has been reported that 
there is no alteration in histatin secretion with respect to 
sex (13). Individuals within the age range of 20-45 years 
were chosen as older individuals have a higher incidence 
of xerostomia that might directly affect salivary histatin 
levels and indirectly affect the study due to increased 
difficulty in sampling (14). Also the possibility of older 
subjects being on some kind of medications and most 
commonly anti- hypertensive medications is very high. 
Time of sample collection was chosen to be around 
10.00 am to 2.00 pm as that is the time of the day when 
the histatin secretion peaks in both the submandibular 
and parotid glands respectively (13).
In order to correlate the levels of salivary histatin to pe-
riodontal disease whole saliva was collected from the 
subjects. It has been stated in the literature that the levels 
of histatin in glandular secretions is higher than in the 
whole saliva (15). The reduction of histatins in whole 
saliva could be due to binding of histatins to hydroxya-
paptite and proteolytic effect of oral microflora on his-
tatin (15). It is the whole saliva that contacts and affects 
the periodontium, hence whole and not glandular saliva 
was chosen to be sampled. Saliva stimulation, both, gus-
tatory or mechanical results in increase of histatin secre-
tion. But this stimulation occurs only during a limited 
period of time in the day. So resting saliva was chosen 
to be sampled (12).
Collection of GCF using microcapillary pipette has been 
widely used (16-18). It has been shown to be a deceiving 
method with respect to sample collection, in clinically 
healthy subjects due to vary little amounts of gingival 
crevicular fluid present in health this could be one of 
the limitations of the study (19). However studies have 
shown that an average of 10-40µl of GCF can be co-
llected in subjects with Gingival and Plaque index score 
of 3. Thus, the use of microcapillary pipettes for GCF 
collection is not a problem for these patients. Also, it 
has the advantage as it is not plagued by the nonspecific 
attachment of the analyte to the filter paper (20).
The results of this study show the presence of histatin 
in saliva of all the samples. The increase in its levels 
with respect to periodontal disease might was slight and 
failed to reach a statistically significant value, sugges-
ting that onset and progression of periodontal disease 
might not have any effect on histatin secretion from the 
salivary glands. Thus its utility as a salivary biomarker 
is questionable and also its role in periodontal disease 
activity i.e., either progression or remission cannot be 
adequately substantiated.
With respect to the levels of histatin in the gingival cre-
vicular fluid all the samples showed its presence but no 
statistically significant difference could be found out 
with respect to the periodontal disease. The origin of his-
tatin in the gingival crevicular fluid could be attributed 
to the characteristic of it being a transudate/exudates and 
that histatin has been detected in the serum in previous 
studies (21). There is no variation in the GCF histatin 
with respect to increase in severity of periodontal disea-
Group Means Std.Dev. Sum of ranks
Group I 0.6289 0.1053 314.5000
Group II 0.6334 0.1115 331.5000
Group III 0.6637 0.0949 389.0000
H-value  1.1782  
P-value  0.5548  
 Pair wise comparison by Mann-Whitney U test
Grp I vs Grp II  0.8035  
Grp I vs Grp III  0.3095  
Grp II vs Grp 
III  0.4186  
Table 4. Comparison of the salivary histatin levels in the three groups 
by Kruskal Walllis ANOVA.
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se. This might be due to the inability of periodontal di-
sease to cause significant change in serum histatin levels 
that are expected to be reflected in the gingival crevi-
cular fluid. This can be confirmed by further studies to 
correlate histatin levels in serum and periodontal disease 
state. Thus failure to detect differences in GCF histatin 
levels disqualifies histatin as a potential biomarker to su-
pervise periodontal health and disease. Also the present 
study raises doubts if histatin does have any role to play 
in pathogenesis of periodontitis.
The results of this study show the presence of histatin in 
the saliva samples of all the subjects. The method used 
in this study to assess histatin levels using ELISA is in 
accordance with the methodology described by Jensen 
JL in 1994 (12). But in those previous studies of histatin 
evaluation, glandular salivary histatins and not whole 
salivary histatins were evaluated. Thus, to the best of 
knowledge, this is the first study to evaluate the who-
le salivary histatins using ELISA technique and hence 
the values cannot be correlated to those of the previous 
studies. 
A mixture of pure histatin 1-12 was not available and 
since the anti-histatin antibodies used were against all 
the histatins no standard curve could be plotted and the 
readings could be obtained only as optical density ratio 
on the ELISA plate reader - though they can still be used 
to quantify and correlate histatins to periodontal health 
and disease though only in terms of optical density. This 
could be considered another shortcoming of the study 
and further quantification should be done using other 
methods of histatin detection. 
With respect to the histatin levels in gingival crevicu-
lar fluid this is the first study to the best of knowledge, 
to assess the presence and quantify it in GCF though a 
previous study that quantified peptides in GCF failed to 
detect histatin (22). So, further studies using other tech-
niques of histatin quantification need to be carried out 
in order to support or refute the findings of the present 
study.
The amounts seen in this study cannot be standardized 
due to the relatively small sample size and further stu-
dies with larger sample size and different quantification 
techniques need to be undertaken.
It can hence be concluded that histatin in gingival crevi-
cular fluid or saliva could not be considered as a poten-
tial biomarker of periodontal disease.
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